V4L Launches Consensus Statement and Report from Forum to Explore the Role of Patient Organisations in Vaccination
Following the IFA-led expert meeting in London, United Kingdom to address the role of advocacy organisations in promoting health through vaccinations, specifically to at-risk groups, the IFA and leading patient organisations in the UK have release a consensus statement and report.
Please find them here:
The Role of Advocacy Organisations in Promoting Health through Vaccination – Consensus Statement
Forum to Explore the Role of Patient Organisations in Vaccination – Expert Meeting Report

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.
The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.
Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.